Myt-healer: a new potent wound healing peptide

Patent number:

WO20109642

Comunidad Valenciana.svg
No items found.

The present invention relates to peptides derived from myticin C and to their therapeutic use, more specifically in cell and/or tissue regeneration.

Countries:
Spain
Regions:
Valencian Community
Centers:
CSIC, UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE
Other entities:
Sectors:
Health
Subsectors:
Pharmaceuticals, Biotechnology
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

- Myt-healer is a short peptide, easy to synthesize - Myt-healer can be used both in aqueous solutions or as a part of a releasing device. - Myt-healer activity is retained in the presence of serum components. - Myt-healer shows a strong wound healing: 5 μM Myt-healer seals the induced injury in HaCaT (Culture Human Keratinocyte) monolayer in 24 h.

Comments

Other related patents

Health

INTRAVENOUS INFUSION DEVICE

Countries
Spain
Know more
Health

A NEW BIOMARKER EXPRESSED IN PANCREATIC BETA CELLS USEFUL IN IMAGING OR TARGETING BETA CELLS

Countries
Belgium
Know more
Health

USE OF PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES

Countries
Spain
Know more
Get back to patents directory